Why drugmakers and hospitals are fighting over the 340B program
At the center is a proposal to shift how drugs are paid for.
Stay updated on 340B Program trends and industry impact. Healthcare Brew provides the latest news and professional analysis on 340B Program's role in Drug Pricing, Access, & Affordability and Pharma.
At the center is a proposal to shift how drugs are paid for.
Program drug spending grew from $6.6 billion in 2010 to $43.9 billion in 2021.
Welcome to the latest installment in Big Pharma vs. Big Hospital.
The federal program faces several challenges in the near future.
The program requires drugmakers to sell discounted drugs to hospitals and clinics.
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.